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Pulmonary infections with nontuberculous mycobacteria (NTM) are recognized as a
problem in immunodeficient individuals and are increasingly common in older people
with no known immune defects. NTM are found in soil and water, but factors influenc-
ing transmission from the environment to humans are mostly unknown. Studies of the
epidemiology of NTM disease have matched some clinical isolates of NTM with isolates
from the patient’s local environment. Definitive matching requires strain level differ-
entiation based on molecular analyses, including partial sequencing, PCR-restriction
fragment length polymorphism (RFLP) analysis, random amplified polymorphic DNA
(RAPD) PCR, repetitive element (rep-) PCR and pulsed field gel electrophoresis (PFGE) of
large restriction fragments. These approaches have identified hospital and residential
showers and faucets, hot-tubs and garden soil as sources of transmissible pathogenic
NTM. However, gaps exist in the literature, with many clinical isolates remaining uni-
dentified within environments that have been tested, and few studies investigating
NTM transmission in developing countries. To understand the environmental reservoirs
and transmission routes of pathogenic NTM, different environments, countries and cli-
mates must be investigated.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.uq.edu.au
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faucets and ice machines [9,10], diagnostic laboratories [11],
bottled and municipal water, commercial and hospital ice
[12], potting soil [13], house dust [14,15], water damaged build-Pulmonary infections with nontuberculous mycobacteria
(NTM) are an increasing problem in many countries.
Symptoms include chronic cough, hemoptysis, weight loss,
fever and progressive fatigue – similar to Mycobacterium
tuberculosis (MTB) pulmonary infection. Diagnoses are made
with chest radiography, detection of acid fast bacilli (AFB) in
sputum and cultures from sputum and bronchoalveolar
lavage (BAL) fluids [1]. The increasing prevalence may reflect
an aging population, as symptomatic infections are most
common in post-menopausal women and older men. NTM
infections can also manifest as lymphadenitis, disseminated
disease, or skin, tissue or bone disease. Disseminated NTM
disease is associated with genetic defects in the Th1 pathway,
and lymphadenitis is often seen in patients with advanced
HIV disease, whilst skin, tissue and bone infections usually
follow trauma at the site of infection. Pulmonary NTM infec-
tions in older individuals with no recognized immune defects
carry a high morbidity and economic cost, as current treat-
ments have multiple side effects and an intention-to-treat
cure rate of <50%. Even in apparent cures, the relapse rate is
50% at 3 years [2]. It is important to determine the source
and mode of transmission of pathogenic strains in the
environment for the advancement of prophylactic measures,
as subtle immune deficiencies are rarely evident prior to the
diagnosis of NTM disease.
Pathogenic NTM comprise many species and strains found
in water and soil. To elucidate NTM disease risk, clinical and
environmental NTM isolates need to be matched. This will
identify critical environmental reservoirs and routes of trans-
mission. The following is a reviewof studieswhere clinical and
environmental strains of mycobacteria were matched and a
discussion of the limitations to the methodologies employed.
NTM are common in many environments
NTM have been isolated from drinking water pipelines [3,4],
water tanks [5], hot tubs [6], residential faucets [7,8], hospitaling materials [16], showerheads [17], shower aerosols [8], hot-
tub aerosols [6], coniferous forest soils [18], brook waters [19],
cigarettes [20], livestock [21], coastal mosses [22] and seawater
[23]. Reports span multiple countries (including the USA,
Australia, the UK, France, the Netherlands, Denmark,
Czechoslovakia, Italy, Finland, Germany, Madagascar,
Tanzania, Taiwan, Japan and Korea) and various climates.
While many isolates were not directly associated with human
disease, these reports show that NTM reside in a variety of
natural and artificial environments.
Environments of interest are defined
Inhalation of aerosols appears to be the primary transmission
route of NTM causing pulmonary disease. This usually occurs
in artificial water environments such as hot-tubs and
showers, but may involve garden soil and house dust.
Mycobacteria may aerosolise more readily than other bacteria
as they have highly hydrophobic cell walls. NTM have been
isolated from natural water environments in which aerosoli-
sation increase the concentration of NTM in the air [24,25].
However, these studies will not be discussed here as the aero-
sols were not linked to NTM disease.
Species-level identification of NTM isolates is sufficient to
determine the presence or absence in an environment, but
strain level identification is required when matching clinical
and environmental isolates. For species level NTM identifica-
tion, cheap lower resolution techniques include phenotypic
and biochemical typing, RT-PCR, species specific DNA probe
kits, HPLC of mycolic acids and sequencing of select genes
(namely 16S, rpoB and/or hsp65). Serotyping [5] and phage typ-
ing [26] have been utilized, but are now less popular as more
species of mycobacteria have been recognized.
With low resolution techniques, environments of interest
can be selected based on assessments of NTM presence.
Demonstrations of transmission causing disease require
higher resolution typing techniques such as RFLP, PFGE, or
Table 1 – Summary of molecular techniques described for NTM strain characterization.
Name Method of characterization Papers describing
the method
Partial sequencing Sequencing of particular genes and gene
fragments (i.e., 16S rDNA).Can directly compare
SNPs of genomic DNA
[47]
[48]
Repetitive sequence PCR (rep-PCR) PCR of genomic DNA with primers specific to
multiple repetitive sequences. Separate
amplicons via gel electrophoresis. Produces
unique fingerprint patterns from multiple
bands of varying intensity
[49]
Random amplification of polymorphic DNA (RAPD) PCR amplification, primers of random sequence
utilised. Polyacrylamide gel electrophoresis
performed on amplicons. Unique fingerprint
generated
[50]
Restriction fragment length polymorphism (RFLP) Perform PCR with primer of interest. Digest
amplicons with restriction enzymes and
determination of fragment length via gel
electrophoresis. Discriminates DNA strands
based on the locations of restriction enzyme
sites (as band patterns)
[51]
Pulsed field gel electrophoresis (PFGE) Amplify Genomic DNA by culture, digest into
large restriction fragments and separate large
restriction fragments via pulsed-field gel
electrophoreses (i.e., Electrophoresis where
voltage periodically changes between three
directions). Capable of accurate discrimination
of sequences in long strands
[52,53]
Amplified fragment length polymorphism (AFLP) Genomic DNA digested with restriction
enzymes, adaptors ligated to restriction
fragments, restriction fragments undergo PCR
amplification, amplified fragments separated
and visualized via polyacrylamide gel
electrophoresis. Polymorphisms scored as
present or absent from genome
[54]
Multiplex PCR Multiple primer sets used in a single PCR
reaction, targeting multiple genes. Amplicon
sizes determined by gel electrophoresis
[55]
High performance liquid chromatography (HPLC) Used to separate, identify, and quantify a
mixture of components in liquid form. For NTM
characterization, it is often used to fingerprint
mycolic acid patterns
[10]
Identification kits Pre-packaged kits designed to identify certain
NTM species. Directions and techniques vary
between kits and manufacturers
[49]
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RT-PCR or gene sequencing provide strain level identification
if optimized correctly (Table 1). These techniques arediscussed
further in Section ‘Molecular methods allow NTM from
patients and their environment to be matched’. When clinical
and environmental isolates are matched at the species level
only, conclusionsshouldbe treatedwithcaution.False-positive
matches may occur when different strains of the same NTM
species are present in different environmental locations [9].
Excessive exposure to NTM-containing aerosols can also
result in hypersensitivity pneumonitis (HP) in people with no
known immune deficiencies. Thiswas documented inmachine
workers following repeated inhalation of aerosolised contami-
nated metal removal fluids [27]. However, the most frequentlyreported cause of NTM HP is aerosolisation of contaminated
hot-tub and swimming pool water, with multiple reports
describing patients who developed NTM HP from these sources
after frequent use [28–34]. Whilst patients with NTM HP can
present acutely and be significantly unwell, most cases resolve
after exposure to the contaminated aerosols is discontinued.
Water
The most credible routes for pulmonary NTM infection
involve inhalation of aerosols generated by hot-tubs and
shower-heads. Indeed, the global increase in NTM infections
may reflect the use of showers rather than bathing [35]. In a
study of particular interest, Feazel et al. used quantitative
84 I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 4 ( 2 0 1 5 ) 8 1 –9 1molecular techniques to show that the showerhead environ-
ment enriches biofilm-forming organisms, including myco-
bacteria [36]. NTM organisms are common in treated water.
Their innate resistance to chlorine and other disinfectants
provides a growth advantage. The disinfectant resistance of
NTM was demonstrated in Australia in a study of
Mycobacterium avium in hot-tubs [37]. Although the bacterial
load excluding mycobacteria was kept at a low 1 CFU/ml by
chlorination, the same samples yielded NTM numbering
between 4.5 · 103 and 4.3 · 104 CFU/ml [37].
Although not affecting the lungs, NTM furunculosis has
also been linked to salon foot-baths used by two patients in
the USA [38]. The infections are attributed to the use of con-
taminated foot baths after shaving of the legs had breached
the skin barrier.
NTM are also present in hospital environments. Earlier
studies linking environmental and clinical NTM isolates
found several NTM species were ubiquitous in hospital
and residential faucets and showers in the UK, the
Netherlands and the Czech Republic [26,39,7]. Diagnosis of
NTM disease can be confounded by false-positive isolates
due to contamination of diagnostic tests, as demonstrated
in the USA [40] and Spain [41]. NTM contaminating hospital
materials can cause nosocomial outbreaks and pseudo-out-
breaks [42,43]. Prevention of nosocomial infections requires
that medical instruments and patient wounds are not
exposed to tap water [1].
Soil
Studies of NTM in soil are less numerous than those of water,
perhaps because soils are considered a less likely/common
source of nosocomial infection and containmore overgrowing
contaminants, complicating NTM isolation from culture.
However, NTM have been isolated from soil in multiple coun-
tries and climates, including Finland [18], Japan [44], the USA
[45] and Uganda [46]. Some reports characterize isolates to the
species level, but only one utilized molecular techniques to
match clinical isolates with NTM isolated from garden soil
[13]. Although the study matched 14 clinical isolates with iso-
lates from the patient’s own gardens, only three were true
matches at the strain level. The authors isolated the organ-
isms by generating aerosols with the soil samples, establish-
ing that the isolates had the potential to be aerosolized to a
respirable particle size.
House dust
Many NTM species have been isolated from house dust [14].
Although these studies used only species specific analyses
for detection and characterization, they establish house dust
as a source of NTM [15]. As dust particles are commonly sus-
pended in the air, inhalation of mycobacteria associated with
dust particles is a plausible source of pulmonary infections.
An early study from Australia used serotyping (one of the first
strain typing techniques described) to match house dust and
patient isolates [47]. Approximately 50% of these house dust
strains were Mycobacterium intracellulare matching the patient
isolates. Further studies utilizing more powerful techniques
are needed to confirm these findings.Molecular methods allow NTM from patients and
their environment to be matched
Within environments identified by low resolution methods,
environmental NTM have been compared with isolates from
patients using molecular techniques. These techniques
(Table 1) have been used as standalone procedures, and as
part of a multistep fingerprinting process. Whilst strain differ-
entiation within some individual species of NTM has been
demonstrated using a single technique, this is not the case
for all. Strain level differentiation across multiple NTM spe-
cies requires a combination of different techniques.
Molecular techniques used for characterization of NTM at
the strain level include high performance liquid chro-
matography (HPLC), repetitive PCR (rep-PCR), random ampli-
fied polymorphic DNA (RAPD) PCR, pulsed-field gel
electrophoresis (PFGE) of large restriction fragments, restric-
tion fragment length polymorphism (RFLP), amplified frag-
ment length polymorphism (AFLP), partial gene sequencing,
and multiplex PCR (i.e., using hsp65, 16S rDNA, ropB, etc.).
Table 2 outlines studies in which these molecular techniques
have been used to identify sources of clinical NTM isolates.
Many PCR-based analyses (e.g., 16s rDNA sequencing) do not
distinguish mycobacterial taxa at the species
level as thegenesareconservedacross thegenus [48]. Forexample,
Mycobacterium kansasii/Mycobacterium gastri and Mycobacterium
abscessus/Mycobacterium chelonae share identical 16S rDNA
sequences. Similar problems also affect NTM differentiation at
the strain level and are avoided by the use of multiple analyses in
tandem [49]. One study describes a comprehensive analyses of
the discriminatory power of 16S rDNA, hsp65, and rpoB gene
sequencing, hsp65 RFLP, rep-PCR, RAPD PCR, and PFGE of large
restriction fragments for isolates of Mycobacterium mucogenicium
andMycobacterium phocaicum. PFGE analysis displayed the greatest
differentiation power showing each environmental isolate as
genetically unique [9]. However, PFGE cannot differentiate all
NTM strains isolated [50] and should be used in combinationwith
other techniques to achieve greater discrimination. It is also labor
and time intensive.
Although not yet utilized in environmental and clinical
isolate matching of NTM, it is becoming increasingly feasible
to perform whole genome sequencing. Whilst offering defini-
tive genomic differentiation of isolates, whole genome
sequencing requires new stratagems in data management
[50]. When more sequences become available, targeted
sequencing for accurate species identification will reduce
costs and increase accessibility. Whole or targeted genome
sequencing will likely replace PFGE as the gold standard for
bacterial strain typing.
Factors defining clinically important sources of
NTM
Geographic location
Relevant studies have been conducted in different countries,
with most from the USA and Australia (Table 2) and a few
from the developing world. The countries best represented
in the literature have a lower prevalence of MTB infection,
Table 2 – (a and b) Summary of studies utilizing molecular methods to differentiate and match clinical and environmental isolates of NTM. Relevant papers were identified
using search engines (Google Scholar, PubMed, UQ Summon and UWA OneSearch) and citations from other papers. The databases were searched using the following
keywords to screen for relevant studies: non-tuberculous mycobacteria, patient, environment, epidemiology, infection, water, dust, soil. All studies cited were available
through the University of Queensland or University of Western Australia subscription services or publicly accessible. The absence of published data is represented by ‘‘NA’’.
Country Clinical samples Environment
investigated
Environmental
samples containing
NTM: Number of
environmental
samples taken
Matched clinical and
environmental NTM
isolates: total
environmental samples
Species matched Species
characterization
method
Strain
characterization
method
Source
(a)
UK Patients (n = 33)
Isolates (n = 36)
Hospital water faucets
(n = 97), tank (n = 5)
57:97 (faucet)
3:5 (tank)
36:102 M. xenopi (n = 36) Culture
Unspecified methods
NA [39]
USA AIDS patient
stool, sputum and
blood (n = 36)
Environmental and
municipal water sources
10:NA 5:NA M. avium (n = 5) Culture
DNA probe kits
(SNAP, Gen-Probe)
PFGE-AseI [60]
USA Patient blood or
bone marrow
(n = 40)
Hospital water (n = 10)
House water (n = 58)
Reservoir water (n = 13)
10:10 (Hospitals)
54:58 (Houses)
12:13 (Reservoirs)
3:10 (Hospitals)
2:58 (Houses)
0:13 (Reservoirs)
M. avium (n = 5) Culture
Serotyping
Species specific DNA
probes (Syngene)
Multilocus Enzyme
Electrophoresis
NA [61]
Canada Patient sputum
(n = 1)
Hot-tub water (n = 1) 1:1 1:1 M. avium (n = 1) Culture
Multilocus Enzyme
Electrophoresis
RFLP (IS1245) [30]
USA Patients (n = 17)
Isolates (n = 19)
Water reservoirs (n = 13)
Residential water (n = 55)
Commercial building
water (n = 31)
Hospital water (n = 15)
12:13 Water
reservoirs
45:55 Residential
water
31:31 Commercial
building water
15:15 Hospital water
3:144 M. avium (n = 3) Culture
Biochemical analyses
DNA probe kits
(SNAP, AccuProbe)
HPLC
PFGE-AseI [62]
USA AIDS and non-
AIDS patients
(n = 103 isolates)
Various vegetables
(n = 121)
25:121 1:121 M. avium (n = 1) Culture
DNA probe kits
(Accuprobe, SNAP)
RFLP
RT-PCR (IS 1245
and IS1311) (M.
avium only)
[63]
USA Patient biopsy
tissue (n = 2)
Nail salon whirlpool bath
swabs (n = 7)
3:7 2:7 M. mageritense
(n = 2)
Culture
Biochemical analyses
PCR-RFLP (hsp65)
HPLC (mycolic acid
esters)
rep-PCR
PFGE-XbaI
[38]
USA Patient sputum
(n = 131)
(n = 161 isolates)
Hospital hot water
system isolates (n = 13)
13:13 85:13 M. avium (n = 85) Culture
PCR-RFLP (hsp65)
Gen-probe DNA
Probes
PFGE-AsnI, XbaI [64]
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Table 2 – (continued)
Country Clinical samples Environment
investigated
Environmental
samples containing
NTM: Number of
environmental
samples taken
Matched clinical and
environmental NTM
isolates: total
environmental samples
Species matched Species
characterization
method
Strain
characterization
method
Source
(a)
Australia Patient sputum
(n = 4)
Spa water (n = 2) 2:2 3:2 M. avium (n = 3) Culture
Phenotypic
characteristics
PFGE-AseI
rep-PCR
(between IS1245
and IS1311)
[37]
Korea Patient blood
culture (n = 12
isolates)
Hospital tap water
n = 100
50:100 2:100 M. mucogenicium
(n = 2)
Culture
PCR-RFLP (ropB) –
MspI, HaeIII
RAPD (10-mer
primer)
[65]
USA Patient sputum
(n = 26)
Commercial potting soil
aerosols (n = 2)
Patient garden soil
aerosols (n = 79)
21:21 3:79 M. intracellulare
(n = 2)
M. avium (n = 1)
Culture
RFLP (hsp65) – HaeIII,
BstEII
Partial sequencing
(16s and 23s rDNA)
PFGE-Xbal [13]
Japan Patient sputum
(n = 30)
Patient residential
bathrooms (showerhead
water (n = 46), kitchen tap
water (n = 48), bathtub
tap (n = 48), showerhead
scale (n = 37), drain slime
(n = 49) and air
conditioners (n = 45))
10:371 (all in
bathrooms)
2:49 M. avium (n = 2) Culture
Phenotypic
characteristics
Partial sequencing
(16s- 23s RNA ITS
region)
Serotyping
RFLP (IS 1245
and IS 1311)
PFGE-Xbal, DraI
[66]
(b)
USA Patient sputum
(n = 1)
Showerhead sediment
(n = 6), hot (n = 6) and
cold (n = 6) bathroom tap
water
6:6 (Hot water)
6:6 (Cold water)
6:6 (Sediment)
1:18 M. avium (n = 1) Culture
Partial sequencing
(16s rDNA)
RFLP (hsp65 and
IS 1245/IS 1311) -
BstEII, HaeIll
[17]
USA Patient blood
(n = 5)
Texas hospital sinks,
showers (n = 13)
Municipal water tank
swabs (n = 2
Municipal water plant
tanks (n = 2)
Hospital swabs (n = 10)
Ice machine ice (n = 1)
12:27 1:27 M. phocaicum
(n = 1)
Culture
Partial sequencing
(hsp65, 16S rRNA, and
rpoB)
rep-PCR
(Box A1R Primer)
RAPD – PCR
(RAPD1 primer)
PFGE – AseI
[9]
USA Patient isolates
(n = 74)
Residential water
supplying patients
homes (n = 23)
23:23 1:23 M. avium (n = 1) Culture
Multilocus Enzyme
Electrophoresis
PFGE-Xbal [67]
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Table 2 – (continued)
Spain Patients (n = 39)
Patient
urine(n = 23
isolates)
Patient sputum
(n = 19 isolates)
Hospital tap water
Urine collection bottles
6:NA (Hospital tap
water)
11:NA (Urine
bottles)
21:NA (Patient urine)
5:NA (Patient sputum)
M. avium (n = 26) Culture
Phenotypic characteristics
DNA Probe kit (AccuProbe
MAC culture identification
kit)
rep-PCR (IS1245
and IS901)
Partial
sequencing
(hsp65, 16S
rDNA)
RFLP (IS 1311) –
HinfI, MseI PFGE
- Xbal
[41]
USA Patients (n = 42) Patient residential water
systems (n = 37)
Total samples taken
(n = 394)
22:37 (houses)
109:394 (individual
samples)
7:37 M. avium (n = 7) Culture
Partial sequencing (16s
rDNA)
rep-PCR [68]
USA Patients (n = 24)
Patient samples
(n = 60)
Hospital water and ice
machines (n = 139)
Household water (n = 5
households)
112:139 (Hospital
water and ice)
4:5 (Residential
water)
5:139 (Hospital water
and ice)
3:5 (Residential
water)
M. porcinum
(n = 8)
Culture
HPLC of mycolic acids
RFLP (hsp65)
PFGE – Xbal, Asel
Partial
sequencing
(hsp65, ropB, recA
and 16s rDNA)
[69]
Australia Patients (n = 20) Patient taps, swimming
pools and rainwater
tanks (n = 20)
19:20 7:20 (Species level)
1:20 (Strain level)
M. abscessus
(n = 3), M. avium
(n = 1), M.
gordonae (n = 1),
M. lentiflavum
(n = 1), and
M. kansasii
(strain level
match)(n = 1)
Culture
RT-PCR and High
Resolution Melt Curve
Partial sequencing (16s
rDNA)
Multiplex PCR
Hain Life Sciences
GenoType Mycobacterium
AS kit
rep-PCR [8]
Australia Patients (n = 68)
Isolates (n = 72)
NTM patient residential
water swabs and aerosols
(n = 16 isolates)
Water from main,
reservoir and distribution
points (n = 220)
n = 16 isolates (NTM
Patient residential
water swabs and
aerosols)
49:220 (Water from
main, reservoir and
distribution points)
6:65 (environmental
isolates)
M. kansasii
(n = 6)
Culture
Phenotypic characteristics
Partial sequencing (hsp65,
16s rDNA)
Multiplex PCR DNA probe
kit (GenoType
Mycobacterium AS
(additional species) kit)
RFLP (16s-23s
ITS rDNA)
rep-PCR
[50]
Australia Patient samples
(n = 74)
Municipal water
Tap water
Tank water
Swimming pool water
15:NA 6:15 (water isolates) M. abscessus
(n = 6)
Culture
Phenotypic characteristics
Partial sequencing (16s
rDNA, hsp65, rpoB)
Multiplex PCR
DNA probe kit (GenoType
Mycobacterium AS
(additional species) kit)
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for research. The imbalance makes it difficult to address the
role of climate and geographical location in the acquisition
of NTM from water and soil. However, NTM does appear to
be widespread in most regions, as is NTM disease [1,51]. It
remains unclear why the species causing disease vary
between countries, but there is potential for climate to influ-
ence the exposure of susceptible people through the preva-
lence of NTM in the environment [52].
Patient exposure
Many common activities expose individuals to pathogenic
NTM. The most studied are hot-tub use [30,37,6], showering
[8,9,17], faucet use [39,53,54] and gardening [13]. These
sources have been investigated by studies matching NTM
strains between the patient and the environment. NTM trans-
mission has also been linked with exposure from commercial
farming [55], aerosolised metalworking fluids [27] and tending
of aquariums [56], but these routes have yet to be confirmed
by matching clinical and environmental strains.
Sources of residential exposure to NTM have been investi-
gated via questionnaire-based surveys [52,57,58]. Exposure to
soil was identified as a risk factor in all three studies, and one
showed more mixed and polyclonal NTM infections in
patients regularly exposed to soil, linking environmental
exposure with disease [57]. NTM disease did not correlate
with exposure to specific foods or to pets [52,58].
Although useful data are provided, the use of surveys is
flawed in that: (1) one exposure event may be enough for
NTM colonization, making accounts of activity frequency less
relevant; (2) isolates were not matched to ascertain that the
source implicated was responsible for NTM disease; and (3)
for a study of the general population, a cohort of 800 is insuf-
ficient in an area with an NTM infection rate of 1.2/100,000
[52]. Some studies have used sensitin skin testing as an indi-
cator of NTM infection [52]. However, sensitin tests reflect
both past and current infections, with a potential for false
positives, and are poor markers of clinical disease.
The low ratio of successful matches between environmen-
tal and clinical isolates is striking. While some studies
matched most clinical isolates with their reservoir [17,37],
this is likely due to the low numbers of participating patients.
Others achieved accurate matches with fewer than 20% of
patient isolates, so any conclusions regarding relative
environmental risk factors are broad extrapolations
[9,13,53,54]. The reservoirs for most clinically infective NTM
remain unknown, but many bacteria in the patient’s immedi-
ate environment are never identified and characterized. The
missing pathogens may have originated from a known
environment of interest (e.g., a showerhead) that was not
sampled for the study, or may have been transmitted via a
novel route. The significant lag time between acquisition of
infection and diagnosis of disease (1–10 years) makes it diffi-
cult to pinpoint the actual source.
Alternatively, human transmission may be responsible for
more infections than is generally suspected. Although this
has rarely been observed, recent studies show links between
isolates from multiple patients [59–61]. These results do not
prove human-to-human transmission, as patients may haveacquired the pathogen from the same environmental reser-
voir. However, this route of NTM infection should not be dis-
missed without further study.
Species and strain infectivity
Species of NTM differ in habitat and in their potential for
human infection. A summary compiled by the American
Thoracic Society shows the relative risk of infection by differ-
ent NTM species in the USA [1].M. kansasii remains one of the
most infective species whilst others (i.e., Mycobacterium
frederiksbergense, Mycobacterium flavescens, Mycobacterium
moriokaense) appear to be non-pathogenic to humans [1]..
Moreover, pathogenicity may vary between strains of the
same species. In a study of clinical isolates of M. kansasii
(n = 191), isolates from different subtypes differed in
pathogenicity based on the percentage of patients infected
[62]. Subtype 1 accounted for a majority of isolates and was
considered pathogenic in 81% of cases, while subtype 3 was
only pathogenic in 6% of cases and was considered a non-
pathogen [63].
Antibiotics play a central role in the treatment of NTM dis-
ease, with individual NTM species and patients requiring dif-
ferent antibiotic cocktails. Difficulties prescribing the correct
treatment arise from the limited ability of in vitro susceptibil-
ity tests to predict antimicrobial responses for all NTM spe-
cies. For example, M. kansasii is susceptible to multiple
antibiotics and M. avium is susceptible to the macrolide
antimicrobials in vivo, but M. abscessus subs abscessus has
inducible resistance to macrolides [1]. In rare cases, side
effects of effective antibiotic treatment outweigh the conse-
quences of the disease.
Strain typing of NTM is not routine clinical care, but could
reveal patterns of pathogenicity and antibiotic resistance pre-
sent in the population. For example, M. abscessus strains with
a functional erythromycin ribosome methyltransferase (erm)
gene are resistant to macrolide antibiotics. Strains lacking a
functional erm gene are susceptible to macrolides in vivo
and in vitro [64].
An understanding of NTM transmission will
facilitate targeted prophylactic measures
NTM are ubiquitous in the environment and vary in infectiv-
ity, pathogenicity and susceptibility to antibiotics. Although
most studies using high resolution molecular techniques
are from the USA and Australia, NTM have been isolated from
similar sources in other countries and climates. The risk of a
particular environmental source transmitting pathogenic
NTM is determined by three variables: (1) the capacity for
pathogenic NTM growth in the environment; (2) the fre-
quency of human exposure from the source in question;
and (3) the method of patient exposure to pathogenic NTM
from the source. Environments of interest are those with high
NTM burdens in a form that is easily aerosolised, namely
showers, hot-tubs, garden soil and house dust.
From studies in which environmental NTM have been
matched by strain to pathogenic isolates, key sources appear
to be hot-tubs, faucets and showerheads, with similar fre-
quencies of isolation from hospitals and private residences.
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patients already infected with NTM. When private residences
of uninfected individuals were sampled, NTM were recovered
at a much lower frequency, suggesting the community at
large has a low risk of infection from household water [53].
Whilst many studies confirm that NTM is transmitted
from water, this may simply reflect the large number of
water-based studies. M. avium has a longstanding link to
water environments, as does M. abscessus [8]. Although
M. kansasii can be found in a tap water, few strains from tap
water matched disease isolates. M. intracellulare infections
were also associated with water, but these waterborne
M. intracellulare isolates have since been reidentified as a
novel species, Mycobacterium chimaera [65]. Although M. intra-
cellulare infection is still commonly reported [66], since this
re-classification there remains no evidence linking water to
M. intracellulare infection. Transmission may involve soil
exposure, which correlates with NTM pulmonary disease in
multiple studies [44,52,57,58] although it has only been con-
firmed as a transmission route via strain-matching in one [13].
Presently, prophylaxis of pulmonary NTM disease involves
avoidance of exposure to possible NTM containing aerosols.
Steps that can be made to reduce levels of NTM in water
include: maintaining hot water system temperatures at above
60 C, and the correct pH and chlorination of pools and spas.
Nosocomial infections can be prevented by cleaning medical
instruments using only sterile water and disinfectant before
use, and use of personal protective equipment can reduce
aerosol inhalation (e.g., when gardening). These precautions
can be recommended to individuals perceived to be at a high
risk of infection. A more extensive understanding of NTM
transmission will allowmore targeted prophylactic measures.
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